Concert Pharmaceuticals, Inc. (CNCE) Stock Price & Growth Analysis

Quote Panel

Updated October 4, 2024

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
401.95M
Shares Outstanding
48.02M
Share in Float
43.66M
Dividende
0

Earning Date
No Data
Price Target
8.37
Average Volume
2.54M
Beta
0.520519

Range
2.72-8.55
Industry
Biotechnology
Website
https://www.concertpharma.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

12.34x

P/S Ratio

2.57x

P/B Ratio

0.1

Debt/Equity

-253.5%

Net Margin

$-3.2

EPS

How CNCE compares to sector?

P/E Ratio

Relative Strength

CNCE

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q2.20

N/A

-0.41
vs -0.78

Q3.20

N/A

-0.60
vs -0.72

Q4.20

N/A

-0.69
vs -0.86

Q1.21

N/A

-0.67
vs -0.70

Q2.21

+139%

0.16
vs -0.41

Q3.21

N/A

-0.78
vs -0.60

Q4.21

N/A

-1.01
vs -0.69

Q1.22

N/A

-1.03
vs -0.67

Q2.22

N/A

-0.59
vs 0.16

Q3.22

N/A

-0.58
vs -0.78

Sales Growth

YoY

Current

Estimates

Q2.20

+12935%

6.4M vs 49K

Q3.20

+14910%

1.5M vs 10K

Q4.20

-46%

7K vs 13K

Q1.21

-29%

5K vs 7K

Q2.21

+401%

32M vs 6.4M

Q3.21

-64%

543K vs 1.5M

Q4.21

+294%

27.6K vs 7K

Q1.22

-100%

NA vs 5K

Q2.22

-100%

21K vs 32M

Q3.22

-99%

8K vs 543K

Return on Equity

QoQ

Q4.20

-17%

-0.17
vs -0.15

Q1.21

-20%

-0.20
vs -0.17

Q2.21

+4%

0.04
vs -0.20

Q3.21

-27%

-0.27
vs 0.04

Q4.21

+20%

0.2
vs -0.27

Q1.22

-51%

-0.51
vs 0.2

Q2.22

-17%

-0.17
vs -0.51

Q3.22

-21%

-0.21
vs -0.17

Institutionnal Ownership

QoQ

Q1.21

93
vs 100

-7%

Q2.21

81
vs 93

-13%

Q3.21

61
vs 81

-25%

Q4.21

53
vs 61

-13%

Q1.22

54
vs 53

Q2.22

72
vs 54

33%

Q3.22

83
vs 72

15%

Q4.22

91
vs 83

10%

Company Description

N/A

12.34x

2.57x

0.1

-253.5%

$-3.2

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!